LE WE PMID CA
Phobia (Neurophysiology)3121Angst (Neurophysiologie)

Aggression (Neurophysiology)

Alcohol

Amygdala

Autism

Cognitive behavior therapy

Cognitive enhancer

D Cycloserine

Depression

Duloxetine

Emotion (Neurophysiology)

Endocannabinoid

Escitalopram

Ghrelin

Hippocampus

Learning and memory (Neurophysiology)

Neuropeptide S

Neuropeptide Y

Obsessive compulsive disorder

Periaquaeductal gray

Phobia (Neurophysiology)

Post traumatic stress disorder

Prefrontal cortex

Pregabalin

Quetiapine

Stress (Neurophysiology)

Yohimbine

2003  
1
Generalized anxiety disorder.
[12938785] South Med J 96(6): 581-6 (2003)
1999  
2
Anxiety disorders in children and adolescents.
[10548164] South Med J 92(10): 946-54 (1999)
2001  
3
Rages and refusals. Managing the many faces of adolescent anxiety.
[11398717] Can Fam Physician 47(-): 1023-30 (2001)
1994  
4
Anxiety disorders in family practice. Diagnosis and management.
[8312758] Can Fam Physician 40(-): 81-8 (1994)
1993  
5
Anxiety disorders. Part 1: Diagnosis and treatment.
[8219867] Can Fam Physician 39(-): 2194-8; 2201 (1993)
1993  
6
Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines.
[8106034] Can Fam Physician 39(-): 2205-8; 2211-3 (1993)
1993  
7
Anxiety disorders. Focus on obsessive-compulsive disorder.
[8348022] Can Fam Physician 39(-): 1612-21 (1993)
2002  
8
Fear knot. Neurobiological disruption of long-term fear memory.
[11872508] Br J Psychiatry 180(-): 195-7 (2002)
2009  
9
The functional neuroanatomy of dread: Functional magnetic resonance imaging insights into generalized anxiety disorder and its treatment.
[19255044] Am J Psychiatry 166(3): 263-5 (2009)
2007  
10
Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
[17898336] Am J Psychiatry 164(10): 1476-88 (2007)
2007  
11
Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
[17267793] Am J Psychiatry 164(2): 290-300 (2007)
2003  
12
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?
[12900305] Am J Psychiatry 160(8): 1432-8 (2003)
2000  
13
Neuroanatomical hypothesis of panic disorder, revised.
[10739407] Am J Psychiatry 157(4): 493-505 (2000)
1998  
14
Panic and phobic anxiety: defining phenotypes for genetic studies.
[9734536] Am J Psychiatry 155(9): 1152-62 (1998)
1998  
15
Panic and phobic anxiety: phenotypes, endophenotypes, and genotypes.
[9734534] Am J Psychiatry 155(9): 1147-9 (1998)
2009  
16
High anxieties: the social construction of anxiety disorders.
[19660164] Can J Psychiatry 54(7): 429-36 (2009)
2006  
17
Clinical practice guidelines. Management of anxiety disorders.
[16933543] Can J Psychiatry 51(8 Suppl 2): 9S-91S (2006)
2000  
18
Childhood anxiety disorders: lessons from the literature.
[11086555] Can J Psychiatry 45(8): 724-30 (2000)
1997  
19
Developments in anxiety disorders.
[9469233] Can J Psychiatry 42(10): 1015-6 (1997)
2008  
20
Relaxation training for anxiety: a ten-years systematic review with meta-analysis.
[18518981] BMC Psychiatry 8(-): 41 (2008)
2006  
21
Predicting danger: the nature, consequences, and neural mechanisms of predictive fear learning.
[16741278] Learn Mem 13(3): 245-53 (2006)
2004  
22
Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction.
[15466303] Learn Mem 11(5): 525-35 (2004)
2009  
23
Duloxetine for the treatment of generalized anxiety disorder: a review.
[19557096] Neuropsychiatr Dis Treat 5(-): 23-31 (2009)
2008  
24
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine.
[19337458] Neuropsychiatr Dis Treat 4(6): 1181-91 (2008)
2008  
25
The role of duloxetine in the treatment of anxiety disorders.
[19183783] Neuropsychiatr Dis Treat 4(5): 929-35 (2008)
2008  
26
2007  
27
The therapeutic potential of escitalopram in the treatment of panic disorder.
[19300618] Neuropsychiatr Dis Treat 3(6): 835-8 (2007)
2007  
28
The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.
[19300556] Neuropsychiatr Dis Treat 3(2): 237-43 (2007)
2006  
29
Experimental animal models for the simulation of depression and anxiety.
[17117614] Dialogues Clin Neurosci 8(3): 323-33 (2006)
2006  
30
Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.
[17227287] CNS Drug Rev 12(3-4): 208-17 (2006)
2007  
31
Modulation of fear and anxiety by the endogenous cannabinoid system.
[17329982] CNS Spectr 12(3): 211-20 (2007)
2007  
32
Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders.
[17192764] CNS Spectr 12(1): 51-6, 59-61 (2007)
2006  
33
Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders.
[17008828] CNS Spectr 11(10 Suppl 12): 29-33 (2006)
2006  
34
Understanding the neurobiology of comorbidity in anxiety disorders.
[17008826] CNS Spectr 11(10 Suppl 12): 13-20 (2006)
2006  
35
Recent advances in the understanding and treatment of anxiety disorders. Resilience: determinants, measurement, and treatment responsiveness.
[17008825] CNS Spectr 11(10 Suppl 12): 5-12 (2006)
2004  
36
Generalized anxiety disorder: acute and chronic treatment.
[15448583] CNS Spectr 9(10): 716-23 (2004)
2009  
37
The pharmacologic treatment of patients with generalized anxiety disorder: where are we now and where are we going?
[19238125] CNS Spectr 14(2 Suppl 3): 5-12 (2009)
1997  
38
Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex.
[9415919] Philos Trans R Soc Lond B Biol Sci 352(1362): 1675-87 (1997)
2004  
39
Panic disorder: psychopathology, medical management and dental implications.
[15270162] J Am Dent Assoc 135(6): 771-8; quiz 796-7 (2004)
2003  
40
Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear.
[12715074] Braz J Med Biol Res 36(5): 557-66 (2003)
2003  
41
Pharmacology of human experimental anxiety.
[12700819] Braz J Med Biol Res 36(4): 421-32 (2003)
2001  
42
The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis.
[11175489] Braz J Med Biol Res 34(2): 145-54 (2001)
2009  
43
The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis.
[19096959] Anxiety Stress Coping 22(1): 5-25 (2009)
2010  
44
Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.
[20393190] Physiol Rev 90(2): 419-63 (2010)
2002  
45
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety.
[12433315] Health Technol Assess 6(22): 1-89 (2002)
2011  
46
Anxiety disorders - assessment and management in general practice.
[21655481] Aust Fam Physician 40(6): 370-4 (2011)
2008  
47
2010  
48
Erasing fear memories with extinction training.
[21068303] J Neurosci 30(45): 14993-7 (2010)
2005  
49
Neuropeptide S: a new player in the modulation of arousal and anxiety.
[15731503] Mol Interv 5(1): 42-6 (2005)
2010  
50
Prefrontal control of fear: more than just extinction.
[20303254] Curr Opin Neurobiol 20(2): 231-5 (2010)
2010  
51
Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.
[20881320] Exp Biol Med (Maywood) 235(10): 1163-7 (2010)
2011  
52
Current management of obsessive and phobic states.
[22003299] Neuropsychiatr Dis Treat 7(-): 599-610 (2011)
2002  
53
The biology of fear- and anxiety-related behaviors.
[22033741] Dialogues Clin Neurosci 4(3): 231-49 (2002)
2002  
54
Psychopharmacology of anxiety disorders.
[22033867] Dialogues Clin Neurosci 4(3): 271-85 (2002)
2002  
55
Nonpharmacological treatments for anxiety disorders.
[22034140] Dialogues Clin Neurosci 4(3): 305-19 (2002)
2010  
56
Neural systems underlying approach and avoidance in anxiety disorders.
[21319496] Dialogues Clin Neurosci 12(4): 517-31 (2010)
2010  
57
Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory.
[20410874] Neuropsychopharmacology 35(8): 1625-52 (2010)
2010  
58
The neurocircuitry of fear, stress, and anxiety disorders.
[19625997] Neuropsychopharmacology 35(1): 169-91 (2010)
2010  
59
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.
[19693004] Neuropsychopharmacology 35(1): 105-35 (2010)
2010  
60
Changing fear: the neurocircuitry of emotion regulation.
[19710632] Neuropsychopharmacology 35(1): 136-46 (2010)
2010  
61
Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine.
[20036429] Trends Pharmacol Sci 31(1): 2-7 (2010)
2007  
62
Elevated mazes as animal models of anxiety: effects of serotonergic agents.
[17401477] An Acad Bras Cienc 79(1): 71-85 (2007)
2003  
63
Panic disorder in children and adolescents.
[12619196] Yonsei Med J 44(1): 174-9 (2003)
2007  
64
The extinction of conditioned fear: structural and molecular basis and therapeutic use.
[17435934] Rev Bras Psiquiatr 29(1): 80-5 (2007)
2008  
65
Structural magnetic resonance imaging in anxiety disorders: an update of research findings.
[18833427] Rev Bras Psiquiatr 30(3): 251-64 (2008)
2010  
66
Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion.
[19836379] Eur J Pharmacol 626(1): 49-56 (2010)
2010  
67
Molecular specificity of multiple hippocampal processes governing fear extinction.
[20458884] Rev Neurosci 21(1): 1-17 (2010)
2010  
68
Glutamate plasticity in the drunken amygdala: the making of an anxious synapse.
[20813244] Int Rev Neurobiol 91(-): 205-33 (2010)
2007  
69
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic.
[17726478] Nat Neurosci 10(9): 1116-24 (2007)
2010  
70
Temperament and the environment in the etiology of childhood anxiety.
[20158575] J Child Psychol Psychiatry 51(4): 497-517 (2010)
2009  
71
Neuroimaging in anxiety disorders.
[18568288] J Neural Transm 116(6): 703-16 (2009)
2011  
72
Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis.
[21735077] Clin Child Fam Psychol Rev 14(3): 302-17 (2011)
2008  
73
Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials.
[18363421] J Clin Psychiatry 69(4): 621-32 (2008)
2011  
74
Fear or disgust? The role of emotions in spider phobia and blood-injection-injury phobia.
[21638233] Turk Psikiyatri Derg 22(2): 115-22 (2011)
2010  
75
Continuing the search for the engram: examining the mechanism of fear memories.
[20569648] J Psychiatry Neurosci 35(4): 221-8 (2010)
2010  
76
Neuropeptide S: a transmitter system in the brain regulating fear and anxiety.
[19523478] Neuropharmacology 58(1): 29-34 (2010)
2005  
77
Overview of diagnosis and drug treatments of anxiety disorders.
[15618947] CNS Spectr 10(1): 49-56 (2005)
2005  
78
The role of glutamate in anxiety and related disorders.
[16400245] CNS Spectr 10(10): 820-30 (2005)
2011  
79
Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder.
[21845177] Front Behav Neurosci 5(-): 44 (2011)
2010  
80
Aggression and anxiety: social context and neurobiological links.
[20407578] Front Behav Neurosci 4(-): 12 (2010)
2010  
81
Interoception in anxiety and depression.
[20490545] Brain Struct Funct 214(5-6): 451-63 (2010)
2008  
82
Anxiety in dementia: a critical review.
[18555569] Clin Psychol Rev 28(7): 1071-82 (2008)
2008  
83
Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.
[17532105] Clin Psychol Rev 28(2): 199-210 (2008)
2008  
84
Models and mechanisms of anxiety: evidence from startle studies.
[18058089] Psychopharmacology (Berl) 199(3): 421-37 (2008)
2010  
85
Ghrelin's Roles in Stress, Mood, and Anxiety Regulation.
[20721341] Int J Pept 2010(-): - (2010)
2010  
86
Early prevention in childhood anxiety disorders.
[21131407] Am J Psychiatry 167(12): 1428-30 (2010)
2011  
87
Cognitive enhancers for anxiety disorders.
[21134394] Pharmacol Biochem Behav 99(2): 275-84 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Angststörungen (F41, F93.0)


  • Search PubMed and many other databases on the combined search terms

    GG: phobia

  • Angst (Neurophysiologie)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia